Archives

by in
Entry Author Date Location
G1, Out to Shield Body From Chemo, Heads to First Clinical Test 07/28/14 Raleigh Durham
How a Little Serendipity Led Acceleron to a Crippling Blood Disease 07/17/14 Boston
West Coast Biotech Roundup: Affymax, K2, Roche/Stratos, & More 06/26/14 San Francisco
Bluebird’s Gene Therapy Quickly Halts Blood Disease in Small Study 06/14/14 Boston
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race 06/09/14 Boston
Promedior Sees Hope in Small Myelofibrosis Study 05/30/14 Boston
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
East Coast Biotech Roundup: HART, CoStim, Forest/Actavis, & More 02/21/14 Boston
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
San Diego Life Sciences Roundup: Arena, Organovo, Isis, & More 06/13/13 San Diego
Rockwell Medical Set to Disrupt Dialysis Treatment With New Drugs, DaVita Deal 05/09/13 Detroit
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly 01/25/12 San Francisco
Acceleron Adds $30M From Partner Celgene and Existing Investors 12/23/11 Boston
Affymax Passes FDA Panel Scrutiny, Looks to Challenge Amgen Anemia Drug 12/07/11 San Francisco
Affymax Shares Climb As FDA Considers Wider Use for Anemia Drug 12/05/11 San Francisco
Affymax Gears Up for its Make-or-Break Moment, As Anemia Drug Faces FDA Scrutiny 11/17/11 San Francisco
Acceleron, Celgene Take Aim at Amgen’s Multibillion-Dollar Anemia Market 08/05/11 Boston
Acceleron Gets $25 Million in Partnership Deal With Celgene 08/03/11 Boston
FDA Says It Will Review Affymax Drug 07/27/11 San Francisco
Affymax Raises $50M 03/18/11 San Francisco
E-Commerce Pioneer Sets Up Cancer Commons, Affymax Hires New Boss, Plexxikon Opts In, & More Bay Area Life Sciences News 01/07/11 San Francisco
Affymax Hires New CEO, Former Genentecher, to Complete FDA Push With Anemia Drug 01/06/11 San Francisco
Alnylam Lays Out 2015 Goals 01/06/11 Boston
Acceleron Pharma Cuts 40 Percent of Workforce 11/03/10 Boston
Taligen Collects $10M For Focus on Rare Diseases 08/23/10 Boston
$8M for Acceleron 06/22/10 Boston
Affymax Tanks on Anemia Results 06/21/10 San Francisco
SS&C Prices IPO, Amag Gets $60M from Takeda, Selecta Nabs $15M, & More Boston-Area Deals News 04/07/10 Boston
Page 1 of 2 next page »